The FirstMark ONC Oncology Health Monitoring Test measures a marker called Tumor Fibrin and Fibrinongen Degradation Products (tFFDP). This marker is a well known by-product of various types of cancer cells and is often found to be elevated in cancer patients during the early stages of the disease. No other test measures these well known markers, and the assessment of tFFDP may provide evidence that cancer is present in the early stages. FirstMark ONC is a self-pay test and generally sells to patients for $189 per test with a physician cost of $159 per test. However, AAPP members who apply to enroll in the FirstMark Physicians’ Network and use the promo code “AAPP” when ordering tests will receive an exclusive additional $25 discount per test! Visit www.thefirstmark.com for more information and to enroll in the FirstMark Physicians’ Network.